SUN PHARMACEUTICAL INDUSTRIES
Back to Cashflow Statement
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹4,959 Cr | ₹8,985 Cr | ₹6,170 Cr | ₹6,555 Cr | ₹2,196 Cr |
What is the latest Cash Flow from Operating Activities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2023 | ₹4,959 Cr |
Mar2022 | ₹8,985 Cr |
Mar2021 | ₹6,170 Cr |
Mar2020 | ₹6,555 Cr |
Mar2019 | ₹2,196 Cr |
How is Cash Flow from Operating Activities of SUN PHARMACEUTICAL INDUSTRIES Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2023 | ₹4,959 Cr | -44.80 | |
Mar2022 | ₹8,985 Cr | 45.61 | |
Mar2021 | ₹6,170 Cr | -5.86 | |
Mar2020 | ₹6,555 Cr | 198.43 | |
Mar2019 | ₹2,196 Cr | - |
Compare Cash Flow from Operating Activities of peers of SUN PHARMACEUTICAL INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMACEUTICAL INDUSTRIES | ₹361,910.4 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics | |
MANKIND PHARMA | ₹92,708.2 Cr | -2.3% | 0.1% | NA | Stock Analytics |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMACEUTICAL INDUSTRIES | 0.3% |
-7.5% |
53.9% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses